VANDA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $131.4M | $33.6M |
| FY2018 | — | $275.4M | $61.0M |
| FY2019 | — | $410.9M | $45.1M |
| FY2020 | — | $453.3M | $61.0M |
| FY2021 | — | $504.9M | $52.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $131.4M | $33.6M |
| FY2018 | — | $275.4M | $61.0M |
| FY2019 | — | $410.9M | $45.1M |
| FY2020 | — | $453.3M | $61.0M |
| FY2021 | — | $504.9M | $52.1M |